Managing the Side Effects of Pancreatic Cancer and Its Treatment
Development of Diabetes
- Excess thirst
- Increased appetite
- Frequent urination
- Feeling shaky or jittery
- Dizziness, fainting
- Fast heartbeat
- Blurry vision
- Chest pain
- Difficulty breathing
- Yellow eyes or skin
- Easy bleeding or bruising
Problems Digesting Food
- Mouth irritation
- Skin rashes
- Abdominal cramps or pain
- Pain or diarrhea
- Stools that look greasy or float on the toilet water
- Difficulty breathing or wheezing
- Hydrocodone (Dilaudid)
- Morphine (Oramorph, MS Contin)
- Methadone (Dolophine)
- Oxycodone (Roxicodone, Oxycontin)
- Fentanyl patch (Duragesic)
Acetaminophen combined with:
- Oxycodone (Percocet)
- Hydrocodone (Vicodin)
- Light-headedness or feeling faint
- Nausea or vomiting
- Constipation—A study found that the medication methylnaltrexone (Relistor) can rapidly relieve this side effect.
Nausea and Vomiting
DiMagno E. Pancreatic carcinoma. In: Cecil Textbook of Medicine. 21st ed. Philadelphia, PA: WB Saunders Company; 2000: 750-752.
Freelove R, Walling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician. 2006;73:485-492.
Lohr JM. Medical treatment of pancreatic cancer. Expert Rev Anticancer Ther. 2007;7:533-544.
What is cancer of the pancreas? American Cancer Society website. Available at: http://www.cancer.org/ . Updated 2007. Accessed June 25, 2008.
What you need to know about cancer of the pancreas. National Cancer Institute website. Available at: http://www.cancer.gov/cancerinfo/wyntk/pancreas#2 . Accessed June 25, 2008.
Yip D, Karapetis C, Strickland A, et al. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev. 2006;3:CD002093.
6/25/2008 DynaMed Systematic Literature Surveillance http://www.dynamicmedical.com/what.php : Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008;358:2332-2343.
11/30/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : US Food and Drug Administration. Propoxyphene: withdrawal—risk of cardiac toxicity. US Food and Drug Administration website. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm234389.htm . Published November 19, 2010. Accessed November 30, 2010.
- Reviewer: Mohei Abouzied, MD, FACP
- Review Date: 09/2014 -
- Update Date: 09/17/2014 -
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © EBSCO Publishing
All rights reserved.